MarketResearchReports.com Premium Membership

Top 10 Oncology Pharma Companies in the World

Top 10 Oncology Pharma Companies in the World
Global oncology market is expected to be worth USD 202.54 billion by 2023 as per newly launched report by NAVADHI Market Research
 
Oncology had the largest revenue share in Global pharmaceuticals market in FY 2018, and it is expected to retain in it’s leadership position even in 2023.
 
Based on the oncology division revenue the top 10 oncology pharmaceutical companies in the world are:
  1. Roche Holding AG : USD 25.659 billion
  2. Celgene Corporation : USD 13.657 billion
  3. Novartis AG : USD 11.811 billion
  4. Bristol-Myers Squibb Company : USD 10.312 billion
  5. Johnson & Johnson : USD 9.844 billion
  6. Merck & Co., Inc. : USD 8.243 billion
  7. Pfizer Inc. : USD 7.202 billion
  8. AstraZeneca PLC : USD 6.028 billion
  9. Eli Lilly : USD 4.260 billion
  10. AbbVie Inc. : USD 3.934 billion
Top 10 Oncology Pharma Companies in the World
 

1. Roche Holding AG

Founded in 1896, Roche Holding AG is one of the world’s largest biotech company, with products in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the in the forefront in-vitro diagnostics and tissue-based cancer diagnostics.

Roche is largest cancer treatment drug manufacturer in the world. In FY 2018 the company's oncology pharma revenue was USD 25.659 billion. Top 3 oncology products of Roche with more than USD 1 billion revenue in FY 2018 were Herceptin, Avastin, MabThera/Rituxan and Perjeta.

2. Celgene Corporation

Celgene Corporation is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation.

Celgene is world's second largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 13.657 billion. Some of the key oncology products of Celgene with more than USD 1 billion revenue in FY 2018 were Revlimid, Pomalyst/Imnovid and Abraxane.

On 3rd January 2019, Bristol-Myers Squibb Company which was ranked 4th based on their FY 2018 oncology revenue announced their plan to acquire Celgene Corporation which was ranked 2nd in the world. The acquisition is expected to cost around USD 90 billion to Bristol-Myers Squibb Company. Post-acquisition Bristol-Myers Squibb Company is expected to give tough competition to Roche Holding AG which is currently world’s top oncology company by FY 2018 revenue.

3. Novartis AG

Novartis AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland. The company manufactures neuroscience, immunology, hepatology and dermatology, ophthalmology, oncology, diabetes, respiratory, cardio-metabolic, hypertension, biopharmaceuticals, anti-infectives, surgical and vision care pharma products.

Novartis is world's third largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 11.811 billion. Some of the key oncology products of Novartis with more than USD 1 billion revenue in FY 2018 were Tasigna, Sandostatin, Gleevec/Glivec, Afinitor/Votubia, Galvus Group, Promacta/Revolade, Tafinlar + Mekinist and Exjade/Jadenu.

4. Bristol-Myers Squibb Company

Bristol-Myers Squibb (BMS) is a global biopharmaceutical company founded in 1933 which focuses on discovering, developing and delivering innovative medicines for patients with serious diseases.

Bristol-Myers Squibb is world's fourth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 10.312 billion. Some of the key oncology products of Bristol-Myers Squibb with more than USD 1 billion revenue in FY 2018 were Opdivo, Sprycel and Yervoy.

5. Johnson & Johnson

Johnson & Johnson was incorporated in the State of New Jersey in 1887. It is organized into three business segments: Consumer, Pharmaceutical and Medical Devices.

Johnson & Johnson is world's fifth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 9.844 billion. Some of the key oncology products of Johnson & Johnson with more than USD 1 billion revenue in FY 2018 were Darzalex, Imbruvica, Velcade and Zytiga.

6. Merck & Co. Inc

Merck & Co., Inc. was founded in 1891 and delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.

Merck & Co. is world's sixth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 8.243 billion. Some of the key oncology products of Merck & Co. with highest revenue in FY 2018 were Keytruda, Emend and Temodar.

7. Pfizer Inc.

Pfizer Inc. is a research-based, global biopharmaceutical company headquartered in New York City, with its research headquarters in Groton.

Pfizer is world's seventh largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 7.202 billion. Some of the key oncology products of Pfizer with highest revenue in FY 2018 were Ibrance, Sutent, Xtandi and Xalkori.

8. AstraZeneca PLC

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory.

AstraZeneca is world's eighth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 6.028 billion. Some of the key oncology products of AstraZeneca with highest revenue in FY 2018 were Tagrisso, Faslodex, Zoladex, Lynparza and Imfinzi.

9. Eli Lilly and Company

Eli Lilly and Company was incorporated in 1901 in Indiana to succeed to the drug manufacturing business founded in Indianapolis, Indiana, in 1876 by Colonel Eli Lilly.

Eli Lilly is world's ninth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 4.26 billion. Some of the key oncology products of Eli Lilly with highest revenue in FY 2018 were Alimta, Cyramza, Erbitux and Lartruvo.

10. AbbVie Inc.

AbbVie Inc.is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. AbbVie’s products are focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson’s disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions.

AbbVie is world's tenth largest oncology pharmaceutical company. In FY 2018 the company's oncology pharma revenue was USD 3.934 billion. Some of the key oncology products of AbbVie with highest revenue in FY 2018 were Imbruvica and Venclexta.
 
Global Oncology Market Forecast 2023

Global oncology market is expected to be worth USD 202.54 billion by 2023.

 

Browse Report

 
 

Related Pharmaceutical Industry Articles

1. Global Pharmaceuticals Market Forecast: Drivers, Value Chain Analysis & Trends

2. Top 15 Pharma Companies in India

3. U.S. Top 10 Pharmaceutical Companies by Market Turnover

4. World's Top Selling Pharmaceutical Drugs and Manufacturers by Sales

5. Top 6 Therapeutic Companies to Look out for Acute Renal Failure (Acute Kidney Injury)

6. Top 10 Antidiabetics Pharma Companies in the World

MarketResearchReports.com Newsletter Subscription

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected